In Vitro Evaluation of Caffeoyl and Cinnamoyl Derivatives as Potential Prolyl Oligopeptidase Inhibitors

被引:9
|
作者
Adolpho, Luciana O. [1 ]
Marin, Daniele [1 ]
Puigpinos, Albert [2 ]
Mendieta, Laura [2 ]
Tarrago, Teresa [2 ]
Morel, Ademir F. [1 ]
Giralt, Ernest [2 ]
Dalcol, Ionara I. [1 ]
机构
[1] Univ Fed Santa Maria, Dept Chem, Nucleo Pesquisa Prod Nat, BR-97105900 Santa Maria, RS, Brazil
[2] Inst Res Biomed, Barcelona, Spain
关键词
prolyl oligopeptidase; dipeptidyl peptidase IV; chlorogenic acid; caffeoyl and cinnamoyl derivatives; Hypericum brasiliense; Hypericaceae; ENDOPEPTIDASE INHIBITOR; ACID-DERIVATIVES; CHLOROGENIC ACID; ANTIOXIDANT; JTP-4819; TARGET; ESTERS;
D O I
10.1055/s-0033-1350897
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
A screening of the natural product chlorogenic acid, isolated from the Brazilian medicinal plant Hypericum brasiliense, caffeic acid, cinnamic acid, and p-methoxycinnamic acid, and derivatives of caffeoylquinic, caffeoyl, and cinnamoyl against the enzymes prolyl oligopeptidase and dipeptidyl peptidase IV was carried out. Caffeoylquinic, caffeoyl, and cinnamoyl derivatives were prepared using simple derivatization procedures and through coupling reactions with the amino acid proline. The dipeptidyl peptidase IV assay showed inhibitory activity of the tested compounds at a high concentration (500 mu M) in the range of 81.5-7.2%. In contrast, the derivatives methyl ester and 1,7-acetonide obtained from chlorogenic acid, and caffeic acid and its methyl ester derivative showed selectivity and activity as prolyl oligopeptidase inhibitors, with IC50 values of 3 to 14mM.
引用
收藏
页码:1531 / 1535
页数:5
相关论文
共 50 条
  • [41] Prolyl oligopeptidase inhibition ameliorates experimental pulmonary fibrosis both in vivo and in vitro
    Laura Cucinotta
    Deborah Mannino
    Giovanna Casili
    Alberto Repici
    Lelio Crupi
    Irene Paterniti
    Emanuela Esposito
    Michela Campolo
    Respiratory Research, 24
  • [42] Design, synthesis and preliminary evaluation of new cinnamoyl pyrrolidine derivatives as potent gelatinase inhibitors
    Zhang, Li
    Zhang, Jie
    Fang, Hao
    Wang, Qiang
    Xu, Wenfang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (24) : 8286 - 8294
  • [43] Cyclic cystine knot peptides are first in class inhibitors of prolyl oligopeptidase with leishmanicide activities
    Hellinger, Roland
    Gattringer, Jasmin
    Schwarz, Paula
    Ramon, Maria
    Gruber, Christian W.
    JOURNAL OF PEPTIDE SCIENCE, 2024, 30
  • [44] Active-Site-Directed Inhibitors of Prolyl Oligopeptidase Abolish Its Conformational Dynamics
    Lopez, Abraham
    Herranz-Trillo, Fatima
    Kotev, Martin
    Gairi, Margarida
    Guallar, Victor
    Bernado, Pau
    Millet, Oscar
    Tarrago, Teresa
    Giralt, Ernest
    CHEMBIOCHEM, 2016, 17 (10) : 913 - 917
  • [45] Novel hydrazone schiff's base derivatives of polyhydroquinoline: synthesis, in vitro prolyl oligopeptidase inhibitory activity and their Molecular docking study
    Talab, Faiz
    Alam, Aftab
    Zainab
    Ullah, Saeed
    Elhenawy, Ahmed A.
    Shah, Syed Adnan Ali
    Ali, Mumtaz
    Halim, Sobia Ahsan
    Khan, Ajmal
    Latif, Abdul
    Al-Harrasi, Ahmed
    Ahmad, Manzoor
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2024,
  • [46] Extracellular prolyl oligopeptidase derived from activated microglia is a potential neuroprotection target
    Natunen, Teemu A.
    Gynther, Mikko
    Rostalski, Hannah
    Jaako, Kulli
    Jalkanen, Aaro J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2019, 124 (01) : 40 - 49
  • [47] Benzimidazolium Salts as Small, Nonpeptidic and BBB-Permeable Human Prolyl Oligopeptidase Inhibitors
    Tarrago, Teresa
    Masdeu, Carme
    Gomez, Elena
    Isambert, Nicolas
    Lavilla, Rodolfo
    Giralt, Ernest
    CHEMMEDCHEM, 2008, 3 (10) : 1558 - 1565
  • [48] Synthesis and activity of pyrrolidinyl- and thiazolidinyl-dipeptide derivatives as inhibitors of the Tc80 prolyl oligopeptidase from Trypanosoma cruzi
    Joyeau, R
    Maoulida, C
    Guillet, C
    Frappier, F
    Teixeira, ARL
    Schrével, J
    Santana, J
    Grellier, P
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2000, 35 (02) : 257 - 266
  • [49] New tricks of prolyl oligopeptidase inhibitors - A common drug therapy for several neurodegenerative diseases
    Svarcbahs, Reinis
    Julku, Ulrika
    Kilpelainen, Tommi
    Kyyro, Mirva
    Jantti, Maria
    Myohanen, Timo T.
    BIOCHEMICAL PHARMACOLOGY, 2019, 161 : 113 - 120
  • [50] Prolyl oligopeptidase and its role in the organism: attention to the most promising and clinically relevant inhibitors
    Babkova, Katerina
    Korabecny, Jan
    Soukup, Ondrej
    Nepovimova, Eugenie
    Jun, Daniel
    Kuca, Kamil
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (10) : 1015 - 1038